Cargando…

Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma

While STAT3 has been validated as a target for treatment of many cancers, including head and neck squamous cell carcinoma (HNSCC), a STAT3 inhibitor is yet to enter the clinic. We used the scaffold of C188, a small-molecule STAT3 inhibitor previously identified by us, in a hit-to-lead program to ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bharadwaj, Uddalak, Eckols, T. Kris, Xu, Xuejun, Kasembeli, Moses M., Chen, Yunyun, Adachi, Makoto, Song, Yongcheng, Mo, Qianxing, Lai, Stephen Y., Tweardy, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041982/ https://www.ncbi.nlm.nih.gov/pubmed/27027445 http://dx.doi.org/10.18632/oncotarget.8368

Ejemplares similares

Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2019)

Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer
por: Bharadwaj, Uddalak, et al.
Publicado: (2014)

Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance
por: Robinson, Prema, et al.
Publicado: (2016)

Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment
por: Kasembeli, Moses M., et al.
Publicado: (2018)

Therapeutic Potential of a Small-Molecule STAT3 Inhibitor in a Mouse Model of Colitis
por: Robinson, Prema, et al.
Publicado: (2023)

Aberrant function of pathogenic STAT3 mutant proteins is linked to altered stability of monomers and homodimers
por: Kasembeli, Moses M., et al.
Publicado: (2023)

Modulation of STAT3 Folding and Function by TRiC/CCT Chaperonin
por: Kasembeli, Moses, et al.
Publicado: (2014)

Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
por: Bharadwaj, Uddalak, et al.
Publicado: (2020)

Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation
por: Xu, Xuejun, et al.
Publicado: (2009)

DRUG-REPOSITIONING SCREENING IDENTIFIED PIPERLONGUMINE AS A DIRECT STAT3 INHIBITOR WITH POTENT ACTIVITY AGAINST BREAST CANCER
por: Bharadwaj, Uddalak, et al.
Publicado: (2014)

Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn’s Disease
por: Robinson, Prema, et al.
Publicado: (2022)

Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts
por: Zakelj, Martina Niksic, et al.
Publicado: (2019)

Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis
por: Wurster, Sebastian, et al.
Publicado: (2022)

TTI-101: A competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain
por: Kasembeli, Moses M., et al.
Publicado: (2021)

Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma
por: Kurth, Ina, et al.
Publicado: (2015)

MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells
por: Huang, Tian-qiao, et al.
Publicado: (2020)

cGAS Regulates the Radioresistance of Human Head and Neck Squamous Cell Carcinoma Cells
por: Nyui, Taichi, et al.
Publicado: (2022)

LAT1 is associated with poor prognosis and radioresistance in head and neck squamous cell carcinoma
por: Kawasaki, Yohei, et al.
Publicado: (2023)

ΔNp63 Regulates Radioresistance in Human Head and Neck Squamous Carcinoma Cells
por: Sato, Kota, et al.
Publicado: (2023)

Contribution of the Type II Chaperonin, TRiC/CCT, to Oncogenesis
por: Roh, Soung-Hun, et al.
Publicado: (2015)

FN1 promotes prognosis and radioresistance in head and neck squamous cell carcinoma: From radioresistant HNSCC cell line to integrated bioinformatics methods
por: Tang, Xiaojun, et al.
Publicado: (2022)

Wnt3a promotes radioresistance via autophagy in squamous cell carcinoma of the head and neck
por: Jing, Qiancheng, et al.
Publicado: (2019)

STAT3 Contributes to Radioresistance in Cancer
por: Wang, Xuehai, et al.
Publicado: (2020)

POPDC3 is a potential biomarker for prognosis and radioresistance in patients with head and neck squamous cell carcinoma
por: He, Xu, et al.
Publicado: (2019)

MicroRNAs Involvement in Radioresistance of Head and Neck Cancer
por: Ahmad, Parwez, et al.
Publicado: (2017)

Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)
por: Skvortsov, S, et al.
Publicado: (2014)

Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma
por: Schoetz, Ulrike, et al.
Publicado: (2021)

Piperlongumine Blocks JAK2-STAT3 to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species(†)
por: Yuan, Hengjie, et al.
Publicado: (2015)

Correction: Piperlongumine Blocks JAK2-STAT3 to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species(†)
por: Yuan, Hengjie, et al.
Publicado: (2016)

CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance
por: Ventelä, Sami, et al.
Publicado: (2014)

Heterogeneous nuclear ribonucleoprotein K is overexpressed and contributes to radioresistance irrespective of HPV status in head and neck squamous cell carcinoma
por: Kähler, Justus, et al.
Publicado: (2020)

The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma
por: Bamps, Marieke, et al.
Publicado: (2021)

ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker
por: Göttgens, Eva-Leonne, et al.
Publicado: (2019)

Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma
por: Routila, Johannes, et al.
Publicado: (2021)

A Four-Gene Signature Associated with Radioresistance in Head and Neck Squamous Cell Carcinoma Identified by Text Mining and Data Analysis
por: Zhang, Yongqian, et al.
Publicado: (2022)

EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer
por: Kim, Song-Hee, et al.
Publicado: (2021)

c-Abl Tyrosine Kinase Is Regulated Downstream of the Cytoskeletal Protein Synemin in Head and Neck Squamous Cell Carcinoma Radioresistance and DNA Repair
por: Deville, Sara Sofia, et al.
Publicado: (2020)

IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma
por: Zang, Chunbao, et al.
Publicado: (2017)

Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses
por: You, Guo-Rung, et al.
Publicado: (2019)

Fitter Mitochondria Are Associated With Radioresistance in Human Head and Neck SQD9 Cancer Cells
por: Grasso, Debora, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_std7blbvphm3vvrslcdmie2t99